Morinaka, Haruka
Kaizaki-Mitsumoto, Asuka
Morohoshi, Hokuto
Uchida, Naoki
Numazawa, Satoshi
Funding for this research was provided by:
JSPS KAKENHI (19K 10693)
Article History
Received: 20 October 2022
Accepted: 26 December 2022
First Online: 6 January 2023
Declarations
:
: The authors declare that they have no conflict of interest.
: All animal experiments were conducted in accordance with the guidelines set by the Science Council of Japan, and the experimental protocol was approved by the Institutional Animal Care and Use Committees of Showa University (Approval No. 23024). Every effort was made to minimize the number of animals used and their suffering. All procedures for the study involving human subjects were conducted in accordance with the Declaration of Helsinki and the Clinical Trials Act, Japan. The study was approved by the Showa University Clinical Research Review Board (Approval No. CRB3200002) and registered with The Japan Registry of Clinical Trials (jRCT) (Trial ID jRCTs031210604, February 9, 2022). All subjects were given a written explanation and written informed consent was obtained before study registration.